Venaxis, Inc. (APPY) Announces Pricing of Offering of Common Stock and Warrants
5/24/2013 10:08:47 AM
More...
|
Venaxis, Inc. (APPY) Appoints SomaLogic, Inc. CMO and Former Pfizer Inc. (PFE) Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
4/19/2013 7:22:50 AM
More...
|
Venaxis, Inc. (APPY) Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-Based Appendicitis Test
3/27/2013 9:58:53 AM
More...
|
Venaxis, Inc. (APPY) to Provide Fourth Quarter 2012 Business Update
3/19/2013 7:14:52 AM
More...
|
Venaxis, Inc. (APPY) Secures Additional European Commercial Development Agreements for APPY1
3/18/2013 10:04:33 AM
More...
|
Venaxis, Inc. (APPY) to Present at 25th Annual ROTH Conference
3/12/2013 6:35:56 AM
More...
|
Venaxis, Inc. (APPY) Executes First Commercial Development Agreement and Receives Purchase Order From EMELCA Bioscience for Initial EU Launch
2/7/2013 9:42:46 AM
More...
|
Venaxis, Inc. (APPY) to Webcast Live at RetailInvestorConferences.com on February 7, 2013
2/4/2013 9:54:07 AM
More...
|
Venaxis, Inc. (APPY) to Present at 2013 Biotechnology Industry Organization (BIO) CEO and Investor Conference
1/23/2013 6:40:03 AM
More...
|
Venaxis, Inc. (APPY) Initiates Patient Enrollment for APPY1 Pivotal Study
1/15/2013 9:46:28 AM
More...
|
|